We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
451
PPG Industries
PPG
$24.9B
$3.14M 0.02%
18,197
-955
-5% -$153K
OLMA icon
452
Olema Pharmaceuticals
OLMA
$977M
$3.11M 0.02%
332,572
-10,000
-3% -$207K
ACC
453
DELISTED
American Campus Communities, Inc.
ACC
$3.09M 0.02%
53,960
+9,141
+20% +$488K
SLM icon
454
SLM Corp
SLM
$4.83B
$3.07M 0.02%
156,247
-167,843
-52% -$3.07M
BABA icon
455
Alibaba
BABA
$276B
$3.07M 0.02%
25,823
-44,570
-63% -$6.49M
CCMP
456
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$3.06M 0.02%
+15,968
New +$2.31M
NUS icon
457
Nu Skin
NUS
$257M
$3.05M 0.02%
60,171
ATO icon
458
Atmos Energy
ATO
$29.7B
$3.04M 0.02%
29,026
-1,566
-5% -$148K
WDAY icon
459
Workday
WDAY
$41.5B
$3.04M 0.02%
11,129
-1,321
-11% -$367K
DOV icon
460
Dover
DOV
$26.7B
$3.03M 0.02%
16,681
-1,323
-7% -$224K
GEN icon
461
Gen Digital
GEN
$16.5B
$2.98M 0.02%
114,569
+18,662
+19% +$472K
YMAB
462
DELISTED
Y-mAbs Therapeutics
YMAB
$2.98M 0.02%
183,692
+5,511
+3% +$118K
AVB icon
463
AvalonBay Communities
AVB
$27.5B
$2.92M 0.02%
11,560
-1,094
-9% -$261K
AZO icon
464
AutoZone
AZO
$51.3B
$2.9M 0.02%
1,383
-140
-9% -$261K
FLOW
465
DELISTED
SPX FLOW, Inc.
FLOW
$2.89M 0.02%
+33,463
New +$2.69M
CARR icon
466
Carrier Global
CARR
$49.8B
$2.88M 0.02%
53,152
-1,465
-3% -$79.1K
PTGX icon
467
Protagonist Therapeutics
PTGX
$8.55B
$2.86M 0.02%
83,646
EIX icon
468
Edison International
EIX
$30.3B
$2.86M 0.02%
41,901
-10,437
-20% -$662K
RSG icon
469
Republic Services
RSG
$67.4B
$2.85M 0.02%
20,449
+2,368
+13% +$315K
MNST icon
470
Monster Beverage
MNST
$95.1B
$2.84M 0.02%
59,120
-6,668
-10% -$296K
JNCE
471
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.82M 0.02%
337,398
KOD icon
472
Kodiak Sciences
KOD
$2.5B
$2.81M 0.02%
33,186
L icon
473
Loews
L
$24.5B
$2.8M 0.02%
48,510
+6,909
+17% +$392K
CNC icon
474
Centene
CNC
$30.5B
$2.8M 0.02%
33,990
-1,372
-4% -$101K
IBN icon
475
ICICI Bank
IBN
$107B
$2.79M 0.02%
141,250
-34,000
-19% -$672K

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.